These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Infant health and neurodevelopmental outcomes following prenatal exposure to duloxetine. Bellantuono C, Marini A, Lucarelli C. Clin Drug Investig; 2013 Sep; 33(9):685-8. PubMed ID: 23873363 [Abstract] [Full Text] [Related]
11. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation. Wohlreich MM, Mallinckrodt CH, Prakash A, Watkin JG, Carter WP. Depress Anxiety; 2007 Sep; 24(1):41-52. PubMed ID: 16845641 [Abstract] [Full Text] [Related]
19. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression. Hellerstein DJ, Stewart JW, McGrath PJ, Deliyannides DA, Batchelder ST, Black SR, Withers A, O'Shea D, Chen Y. J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348 [Abstract] [Full Text] [Related]
20. Long-term safety of duloxetine during open-label compassionate use treatment of patients who completed previous duloxetine clinical trials. Pangallo BA, Zhang Q, Desaiah D, Perahia DG, Detke MJ, Kennedy SH. Curr Med Res Opin; 2010 Nov; 26(11):2643-51. PubMed ID: 20932222 [Abstract] [Full Text] [Related] Page: [Next] [New Search]